0001808805-22-000101.txt : 20220928
0001808805-22-000101.hdr.sgml : 20220928
20220928160157
ACCESSION NUMBER: 0001808805-22-000101
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220926
FILED AS OF DATE: 20220928
DATE AS OF CHANGE: 20220928
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sankar Subramanian
CENTRAL INDEX KEY: 0001856744
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39434
FILM NUMBER: 221275986
MAIL ADDRESS:
STREET 1: C/O NAUTILUS BIOTECHNOLOGY, INC.
STREET 2: 201 INDUSTRIAL RD. #310
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nautilus Biotechnology, Inc.
CENTRAL INDEX KEY: 0001808805
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2701 EASTLAKE AVE EAST
CITY: SEATTLE
STATE: WA
ZIP: 98102
BUSINESS PHONE: 206-333-2001
MAIL ADDRESS:
STREET 1: 2701 EASTLAKE AVE EAST
CITY: SEATTLE
STATE: WA
ZIP: 98102
FORMER COMPANY:
FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp III
DATE OF NAME CHANGE: 20200408
4
1
wf-form4_166439528878324.xml
FORM 4
X0306
4
2022-09-26
0
0001808805
Nautilus Biotechnology, Inc.
NAUT
0001856744
Sankar Subramanian
C/O NAUTILUS BIOTECHNOLOGY, INC.
2701 EASTLAKE AVENUE EAST
SEATTLE
WA
98102
0
1
0
0
Senior VP, Product Development
Common Stock
2022-09-26
4
P
0
10000
2.025
A
86250
D
Common Stock
2022-09-27
4
P
0
5000
2.0298
A
91250
D
Represents the weighted average share price of an aggregate total of 10,000 shares purchased in the price range of $2.00 to $2.05 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Includes 1,250 shares of Common Stock acquired on June 1, 2022 through the Issuer's 2021 Employee Stock Purchase Plan.
Represents the weighted average share price of an aggregate total of 5,000 shares purchased in the price range of $2.02 to $2.04 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
/s/ Matthew B. Murphy, as Attorney-in-Fact
2022-09-27